Navigation Links
Pharma Industry Leaders to Reveal Hottest, Latest Trends for Pharma & Biotech at Groundbreaking Event

PARSIPPANY, N.J., Jan. 12, 2011 /PRNewswire/ -- In 2011, what will be the major trends in the pharmaceutical industry?  What will drive innovation?  How will government regulations affect what's next and what's new?  What will the game changers be?  Who will survive in the competitive corporate landscape?  When it comes to market research, what's the smartest and most effective way to get the job done right? The answers to these questions and much more will be revealed at a pivotal, groundbreaking event - the Pharma Market Research Conference on February 1-2, in Parsippany, New Jersey.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research.  This is the most important and impactful event in pharmaceutical market research.  Nowhere else will you find the industry's best and brightest all under one roof!  

Located in the heart of New Jersey's Pharmaceutical Corridor, this event is an essential destination that shines a spotlight on the pharma industry for the world's most noteworthy market research executives.

The Pharma Market Research Conference's impressive advisory board includes senior-level thought leaders from Bayer, Eisai, Johnson & Johnson, Lundbeck, Merck, Pfizer, Purdue, Shire, and Takeda.  With their executive leadership, the Pharma Market Research Conference offers an intensive agenda for anyone wanting to network with and learn from the industry's best.

Talented speakers come from world class companies, including Abbott, Acorda Therapeutics, Alkermes, Allergan, AstraZeneca, Covidien, Daiichi Sankyo, Eisai, Johnson & Johnson, Lundbeck, Merck, Novartis, Pfizer, Roche, Shire, Takeda, ViroPharma & more!  For more about the speakers, go to:

See what exciting innovations and solutions are being offered by 2011's premier sponsors/exhibitors, which include Ipsos Health, Segmedica, Affinnova, A+A Research, BioMedTracker, CBR Pharma Insights, ClarityQMR, Docnography, Dolcera, Drug Development Insights, Epocrates, Financial Times, Healogix, HRA Research, Life Science Analytics, ListenLogic, M3 Global Research, Medefield, MedPredict, Murray Hill Center, National Analysts Worldwide, Northern Light, Optimal Strategix, Reckner, The Research Partnership, Survey Sampling, Toluna, Truth On Call, Verilogue, and WorldOne.

The Pharma Market Research Conference only happens once a year.  More than 200 people came last time; 2011 is expected to be even bigger and better.  For more information or to register, call + or go to:

SOURCE Pharma Market Research Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda SyMRI ... (MR-bilder) för patienter med multipel skleros ... forskningsavtal med SyntheticMR AB för att kunna ... på sjukhuset. Med SyMRI kan man generera ...
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
Breaking Medicine Technology:
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... at the recent 2015 American Dental Association meeting in Washington D.C. revolved around the ... protect a patient’s overall health. The talk stressed the link between periodontal disease (more ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with ... digital component is distributed nationally, through a vast social media strategy and across ...
(Date:11/27/2015)... ... 2015 , ... Intellitec Solutions announced today that they have ... as Microsoft’s official group for end users of Dynamics SL ERP software, the ... experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing commitment to the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
Breaking Medicine News(10 mins):